Overview
SCIENTIFIC SCORE
Questionable
Based on 11 Researches
6.5
USERS' SCORE
Good
Based on 6 Reviews
8.4
Supplement Facts
Serving Size: 1 Tablet
Amount Per Serving
%DV
Vitamin D3 (Cholecalciferol)
25 mcg (1,000 IU)
130%
Vitamin K K-2 (MK-4) (Menaquinone)
100 mcg
80%
Calcium (as dicalcium phosphate)
32 mg
2%
Top Medical Research Studies
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
8
We examined how vitamin D3 could play a role in protecting the heart from damage caused by cisplatin, a chemotherapy drug. In our research, we worked with male Balb-c mice, dividing them into several groups to evaluate different treatment approaches. Some groups received vitamin D3 before or after cisplatin injection, while others acted as controls.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
4
We investigated how vitamin D3 treatment affects heart disease, particularly focusing on the connection between aortic calcification and cardiac dysfunction. In our study, C57BL/6 mice received daily doses of vitamin D for two weeks, allowing us to observe various factors such as arterial elasticity and cardiac health over an extended period.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
As we analyzed the results, we found that vitamin D treatment led to significant aortic calcification and increased pulse propagation velocity. Unfortunately, rather than improving heart function, this treatment correlated with worsened cardiac performance and increased apoptosis, or programmed cell death, among heart cells.
By examining rat heart cells exposed to media from calcified vascular smooth muscle cells, we noticed a similar trend—these conditions caused apoptosis and altered the expression of genes crucial for heart function. Overall, our findings suggest that while vitamin D is often associated with health benefits, in this context, it accelerates cardiac dysfunction through mechanisms like inducing cell death in heart tissues.
These results offer critical insights into the potential dangers of elevated vitamin D levels, particularly in relation to heart health. They highlight the need for further research to better understand these effects and guide treatment strategies for those at risk of heart disease.
Most Useful Reviews
10
Directs calcium effectively
5 people found this helpful
Vitamin K2 directs calcium utilisation in the body, ensuring it strengthens bones and teeth while preventing accumulation in blood vessels, which is crucial to avoid numerous health risks, including heart disease. Its role in calcium absorption and distribution is paramount to maintaining good health.
9
Beneficial for heart
5 people found this helpful
This supplement is exceptionally beneficial for individuals with heart issues. I found it to be a very good combination of components to support heart health.
9
Decreases aortic calcification
This product offers good value. It significantly lowers the calcification of the aorta, which is essential, especially for older individuals. I bought it for my mother, and it’s wonderful to care for loved ones.
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 11 Researches
6.5
- All Researches
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
8
Vitamin D3 shows potential heart protection
We explored the effects of vitamin D3 and paricalcitol on heart health, particularly in the context of doxorubicin-induced cardiotoxicity. In our study, we worked with male Wistar rats divided into various groups, some receiving doxorubicin, a drug known for its heart-damaging potential. Others were treated with vitamin D3 or paricalcitol, both thought to have protective qualities against heart injury.
After administering doxorubicin, we observed significant changes in a range of biochemical markers and physiological indicators, including ECG readings and scintigraphy results. The findings suggested that both vitamin D3 and paricalcitol demonstrate potential cardioprotective effects by reducing inflammation and oxidative stress linked to heart damage.
This study shines a light on the possible benefits of vitamin D3 in protecting the heart during chemotherapy treatments. However, readers should note that while our findings are promising, they stem from an animal model, and further research is needed to confirm these effects in humans.
After administering doxorubicin, we observed significant changes in a range of biochemical markers and physiological indicators, including ECG readings and scintigraphy results. The findings suggested that both vitamin D3 and paricalcitol demonstrate potential cardioprotective effects by reducing inflammation and oxidative stress linked to heart damage.
This study shines a light on the possible benefits of vitamin D3 in protecting the heart during chemotherapy treatments. However, readers should note that while our findings are promising, they stem from an animal model, and further research is needed to confirm these effects in humans.
8
We examined how vitamin D3 could play a role in protecting the heart from damage caused by cisplatin, a chemotherapy drug. In our research, we worked with male Balb-c mice, dividing them into several groups to evaluate different treatment approaches. Some groups received vitamin D3 before or after cisplatin injection, while others acted as controls.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
7
We explored the effects of vitamin D3, a vital nutrient, on heart health, particularly in relation to a common risk factor known as angiotensin II. Our study focused on H9c2 cardiomyoblasts, a type of heart cell, to understand how vitamin D3 interacts with this condition.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
7
We delved into how vitamin D, specifically its receptor activation with ligands like calcitriol, influences heart health when glucocorticoids are involved. Our research showed that glucocorticoids, while effective as immunosuppressants, can harm the musculoskeletal and cardiac systems, leading to significant issues such as falls, fractures, and cardiovascular events in long-term users.
Notably, we discovered that glucocorticoids trigger the expression of certain proteins, known as atrogenes, in bones, muscles, and the heart, which promote protein degradation. However, activating the vitamin D receptor helped prevent this negative response in all three tissues. This protective effect was also supported by the use of carfilzomib, which inhibits the proteasome directly.
Additionally, when we looked at genetic changes alongside glucocorticoid treatment, we noted that mice lacking a specific atrogene, MuRF1, experienced less damage in their skeletal and heart muscles. This suggests that targeting the pathway related to MuRF1 may offer a strategy to cushion the adverse impacts of glucocorticoids on these tissues. Ultimately, our findings highlight vitamin D’s potential role in safeguarding heart and muscle health amidst glucocorticoid treatment.
Notably, we discovered that glucocorticoids trigger the expression of certain proteins, known as atrogenes, in bones, muscles, and the heart, which promote protein degradation. However, activating the vitamin D receptor helped prevent this negative response in all three tissues. This protective effect was also supported by the use of carfilzomib, which inhibits the proteasome directly.
Additionally, when we looked at genetic changes alongside glucocorticoid treatment, we noted that mice lacking a specific atrogene, MuRF1, experienced less damage in their skeletal and heart muscles. This suggests that targeting the pathway related to MuRF1 may offer a strategy to cushion the adverse impacts of glucocorticoids on these tissues. Ultimately, our findings highlight vitamin D’s potential role in safeguarding heart and muscle health amidst glucocorticoid treatment.
User Reviews
USERS' SCORE
Good
Based on 6 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
10
Directs calcium effectively
5 people found this helpful
Vitamin K2 directs calcium utilisation in the body, ensuring it strengthens bones and teeth while preventing accumulation in blood vessels, which is crucial to avoid numerous health risks, including heart disease. Its role in calcium absorption and distribution is paramount to maintaining good health.
9
Beneficial for heart
5 people found this helpful
This supplement is exceptionally beneficial for individuals with heart issues. I found it to be a very good combination of components to support heart health.
9
Decreases aortic calcification
This product offers good value. It significantly lowers the calcification of the aorta, which is essential, especially for older individuals. I bought it for my mother, and it’s wonderful to care for loved ones.
7.5
Less heart pain
1 people found this helpful
I purchased this for my mother, and she noticed reduced heart pain and more stable blood pressure, which made me very happy.
4
Supports heart health
1 people found this helpful
Vitamin D3 plays a role in regulating calcium metabolism and cellular processes, including the synthesis of antibiotics. A deficiency in vitamin K2 leads to weak bones and cardiovascular issues owing to calcium accumulation in arteries. This deficiency is increasingly problematic, linked to multiple health concerns such as osteoporosis and frequent fractures, which contributes to heart disease risks. I enjoy shopping at IHERB for its excellent product quality and quick international delivery.
Frequently Asked Questions
7.5
Less heart pain
1 people found this helpful
I purchased this for my mother, and she noticed reduced heart pain and more stable blood pressure, which made me very happy.
9
Decreases aortic calcification
This product offers good value. It significantly lowers the calcification of the aorta, which is essential, especially for older individuals. I bought it for my mother, and it’s wonderful to care for loved ones.
9
Beneficial for heart
5 people found this helpful
This supplement is exceptionally beneficial for individuals with heart issues. I found it to be a very good combination of components to support heart health.
10
Directs calcium effectively
5 people found this helpful
Vitamin K2 directs calcium utilisation in the body, ensuring it strengthens bones and teeth while preventing accumulation in blood vessels, which is crucial to avoid numerous health risks, including heart disease. Its role in calcium absorption and distribution is paramount to maintaining good health.
4
Supports heart health
1 people found this helpful
Vitamin D3 plays a role in regulating calcium metabolism and cellular processes, including the synthesis of antibiotics. A deficiency in vitamin K2 leads to weak bones and cardiovascular issues owing to calcium accumulation in arteries. This deficiency is increasingly problematic, linked to multiple health concerns such as osteoporosis and frequent fractures, which contributes to heart disease risks. I enjoy shopping at IHERB for its excellent product quality and quick international delivery.
8
Vitamin D improves heart health
We conducted a double-blind, randomized clinical trial to explore how treating vitamin D deficiency affects heart health, specifically in patients with ischemic heart disease (IHD). In our study, we involved 44 patients aged between 40 and 65 who were dealing with low vitamin D levels. They were divided into two groups—one receiving vitamin D supplements and the other a placebo.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
Over five weeks, patients in the intervention group received weekly doses of 50,000 units of vitamin D. We measured changes in their lipid profiles, which includes important markers like cholesterol and triglycerides, as well as C-reactive protein (CRP), an indicator of inflammation.
Our findings revealed that vitamin D supplementation led to significant improvements. Patients in the intervention group showed an increase in good cholesterol (HDL) and a decrease in triglycerides, which are both beneficial for heart health. While the placebo group also experienced some minor improvements, the notable changes were primarily in the group receiving vitamin D.
Overall, these results suggest that addressing vitamin D deficiency can have positive effects on lipid levels in IHD patients. This is an encouraging insight for healthcare providers looking to manage heart disease risk more effectively.
7
We explored the effects of vitamin D3, a vital nutrient, on heart health, particularly in relation to a common risk factor known as angiotensin II. Our study focused on H9c2 cardiomyoblasts, a type of heart cell, to understand how vitamin D3 interacts with this condition.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
By exposing these cells to angiotensin II along with vitamin D3, we aimed to see if the vitamin could shield the cells from damage. Interestingly, we found that vitamin D3 showed significant potential for preventing cell damage when SIRT1, a protein involved in cell survival, was present. However, when we blocked SIRT1, vitamin D3 wasn’t able to protect the heart cells effectively against the harmful effects induced by angiotensin II.
While vitamin D3 did help mitigate some effects of hypertrophy, or heart cell enlargement, it was clear that SIRT1 was crucial for the vitamin's protective benefits. This finding suggests that enhancing SIRT1 activity could be an exciting path forward for developing treatments to combat heart disease linked to hypertrophy and other conditions related to angiotensin II.
8
We examined how vitamin D3 could play a role in protecting the heart from damage caused by cisplatin, a chemotherapy drug. In our research, we worked with male Balb-c mice, dividing them into several groups to evaluate different treatment approaches. Some groups received vitamin D3 before or after cisplatin injection, while others acted as controls.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
Our findings revealed that cisplatin significantly raised markers indicating heart damage and increased oxidative stress levels. In contrast, when we administered vitamin D3, whether as a preventive measure or treatment after cisplatin exposure, it showed promising results. It was able to improve heart tissue structure and biochemical indicators associated with heart injury, suggesting that vitamin D3 may mitigate some of the cardiac risks linked with chemotherapy.
However, while vitamin D3 showed a protective effect in the groups that received it before cisplatin treatment, the benefits were only partial when given afterward. This highlights the potential of vitamin D3 in supporting heart health during cancer treatment, although more research is necessary to understand its full capabilities and best applications.
4
We explored the effects of vitamin D3 in conjunction with marine n-3 fatty acids on heart disease, specifically looking at a large-scale study known as the VITAL trial. This secondary analysis involved over 25,000 healthy older adults who were given either a daily supplement of 1 gram of marine n-3 fatty acids and vitamin D3 or a placebo.
The primary focus was to see if these supplements could lower the risk of cardiovascular disease events. We examined various heart-related outcomes, including fatal coronary heart disease, other fatal cardiovascular issues like strokes, and non-fatal events such as heart attacks.
Our findings revealed that there was no significant overall benefit from vitamin D3 on heart disease risk when combined with n-3 fatty acids. Specifically, while we did see a reduction in heart attacks among those who consumed less fish, the data suggested that the benefits were not substantial enough to make a definitive claim about the efficacy of vitamin D3 alone.
Ultimately, although we observed some protective effects for certain individuals, the overall results indicated that vitamin D3 may not significantly impact heart disease risk when evaluated alongside n-3 fatty acids.
The primary focus was to see if these supplements could lower the risk of cardiovascular disease events. We examined various heart-related outcomes, including fatal coronary heart disease, other fatal cardiovascular issues like strokes, and non-fatal events such as heart attacks.
Our findings revealed that there was no significant overall benefit from vitamin D3 on heart disease risk when combined with n-3 fatty acids. Specifically, while we did see a reduction in heart attacks among those who consumed less fish, the data suggested that the benefits were not substantial enough to make a definitive claim about the efficacy of vitamin D3 alone.
Ultimately, although we observed some protective effects for certain individuals, the overall results indicated that vitamin D3 may not significantly impact heart disease risk when evaluated alongside n-3 fatty acids.
7
We examined the role of a specific form of vitamin D3, known as 3-epi-25(OH)D3, in relation to cardiovascular health in patients with advanced chronic kidney disease (CKD). By analyzing data from 165 patients—some who had received kidney transplants and others who were still on the waiting list—we were able to observe changes in their vitamin D levels over time and how this relates to their heart health.
Our findings highlighted that patients with lower levels of 3-epi-25(OH)D3 tended to have reduced physical capacity, specifically a lower peak oxygen uptake during exercise testing. Interestingly, after kidney transplantation, vitamin D3 levels increased, while they declined in those still awaiting a transplant. However, despite these fluctuations, we found that 3-epi-25(OH)D3 was linked to improvements in exercise capacity but did not show significant associations with other cardiovascular measures like left ventricular mass or arterial stiffness.
Ultimately, while changes in 3-epi-25(OH)D3 levels appear to influence exercise capacity in CKD patients, the study did not find compelling evidence that vitamin D3 directly benefits heart disease risk. It seems we have more to learn about how vitamin D3 affects cardiovascular health.
Our findings highlighted that patients with lower levels of 3-epi-25(OH)D3 tended to have reduced physical capacity, specifically a lower peak oxygen uptake during exercise testing. Interestingly, after kidney transplantation, vitamin D3 levels increased, while they declined in those still awaiting a transplant. However, despite these fluctuations, we found that 3-epi-25(OH)D3 was linked to improvements in exercise capacity but did not show significant associations with other cardiovascular measures like left ventricular mass or arterial stiffness.
Ultimately, while changes in 3-epi-25(OH)D3 levels appear to influence exercise capacity in CKD patients, the study did not find compelling evidence that vitamin D3 directly benefits heart disease risk. It seems we have more to learn about how vitamin D3 affects cardiovascular health.
References
- Astani A, Maroofi A, Hekmatimoghaddam S, Sarebanhassanabadi M, Safari F. Sirtuin 1 mediates the pro-survival effects of vitamin D in angiotensin II-induced hypertrophy of H9c2 cardiomyoblasts. Mol Biol Rep. 2024;52:96. doi:10.1007/s11033-024-10168-6
- Sadeghi M, Momeni A, Mirsaeidi FS, Jamalian M, Amirpour A, et al. The Effect of Vitamin D Deficiency Treatment on Lipid Profile and C-reactive Protein in Patients with Ischemic Heart Disease: Double-blind Randomized Clinical Trial. Adv Biomed Res. 2024;13:79. doi:10.4103/abr.abr_380_23
- Sato AY, Cregor M, McAndrews K, Schurman CA, Schaible E, et al. Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease. JCI Insight. 2024;9. doi:10.1172/jci.insight.182664
- Stankiewicz B, Mieszkowski J, Kochanowicz A, Brzezińska P, Niespodziński B, et al. Effect of Single High-Dose Vitamin D Supplementation on Post-Ultra Mountain Running Heart Damage and Iron Metabolism Changes: A Double-Blind Randomized Controlled Trial. Nutrients. 2024;16. doi:10.3390/nu16152479
- Koroglu R, Koroglu M, Aygun H. Electrocardiographic, biochemical, and scintigraphic evidence for the cardioprotective effect of paricalcitol and vitamin D3 on doxorubicin-induced acute cardiotoxicity in rats. Bratisl Lek Listy. 2024;125:281. doi:10.4149/BLL_2024_42
- Hao N, Yong H, Zhang F, Liu C, Qiu Y, et al. Aortic calcification accelerates cardiac dysfunction via inducing apoptosis of cardiomyocytes. Int J Med Sci. 2024;21:306. doi:10.7150/ijms.90324
- Samavati I, Ranjbar A, Haddadi R. Cardioprotective effect of vitamin D3 on cisplatin-induced cardiotoxicity in male mice: role of oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:4761. doi:10.1007/s00210-023-02848-0
- Ogata S, Manson JE, Kang JH, Buring JE, Lee IM, et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite Outcomes. Nutrients. 2023;15. doi:10.3390/nu15194235
- Arroyo E, Leber CA, Burney HN, Li Y, Li X, et al. Epimeric vitamin D and cardiovascular structure and function in advanced CKD and after kidney transplantation. Nephrol Dial Transplant. 2024;39:264. doi:10.1093/ndt/gfad168
- Hasific S, Øvrehus KA, Hosbond S, Lambrechtsen J, Kumarathurai P, et al. Effects of vitamins K2 and D3 supplementation in patients with severe coronary artery calcification: a study protocol for a randomised controlled trial. BMJ Open. 2023;13:e073233. doi:10.1136/bmjopen-2023-073233
- Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. doi:10.1136/bmj-2023-075230
